Dec 05, 2023
FDA Grants Priority Review to Merck’s Application for KEYTRUDA Plus Padcev for the First-Line Treatment of Patients With Locally Advanced or Metastatic Urothelial Cancer Merck, operating as MSD internationally, reported that the U.S. Food and Drug Administration (FDA) has prioritized the review of a supplementar...
Read More...
May 20, 2019
The summer has arrived, and so has the season of Lyme. The number of Lyme disease cases invariably rises as the months of June and July approach. According to the CDC, the number of Lyme diseases diagnosed cases each year is 30,000. And this number is likely to cross 40,000 each year in the United States. The Lyme ...
Read More...
Intratumoral Cancer Therapy: A Potential Weapon To Fight the Battle Against Cancer
Aug 05, 2026
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Newsletter/Whitepaper